Horizon Technology Finance Announces Transformational Merger with Monroe Capital, Issuing 23M Shares and Gaining $162M Cash
summarizeSummary
Horizon Technology Finance is merging with Monroe Capital Corporation, a deal that includes issuing approximately 23.0 million new shares and receiving $162.4 million in cash, aiming for enhanced scale and long-term NII accretion.
check_boxKey Events
-
Merger Agreement Signed
Horizon Technology Finance Corporation (HRZN) and Monroe Capital Corporation (MRCC) entered into a definitive merger agreement on August 7, 2025, with a special stockholder meeting scheduled for March 13, 2026, to approve the transaction.
-
Significant Share Issuance
HRZN is expected to issue approximately 23.0 million shares of common stock to MRCC stockholders, resulting in existing HRZN shareholders owning 65.9% of the combined company and MRCC shareholders owning 34.1%.
-
Substantial Cash Infusion
HRZN expects to receive approximately $162.4 million in cash proceeds from MRCC's asset sale to Monroe Capital Income Plus Corporation (MCIP) immediately prior to the merger.
-
Management Fee Waiver
The HRZN Advisor has agreed to waive $4.0 million in base management and/or incentive fees, at a rate of $1.0 million per quarter for four quarters, following the merger's completion.
auto_awesomeAnalysis
Horizon Technology Finance (HRZN) is undertaking a significant strategic merger with Monroe Capital Corporation (MRCC), which is expected to be transformational for the company. The transaction involves HRZN issuing approximately 23.0 million shares, which represents a substantial increase in outstanding shares and will result in significant dilution for existing HRZN shareholders, who will own 65.9% of the combined entity. Concurrently, HRZN will receive a substantial cash infusion of approximately $162.4 million from MRCC's asset sale to Monroe Capital Income Plus Corporation (MCIP) prior to the merger. This capital is intended to support HRZN's next phase of growth, enhance scale and diversification, and is expected to be accretive to net investment income over time. Additionally, the HRZN Advisor has agreed to a $4.0 million fee waiver over four quarters, which will reduce operating expenses for the combined company. While the dilution is notable, the strategic benefits of increased scale, diversification, and capital for investment are expected to drive long-term value, as unanimously recommended by both companies' boards.
At the time of this filing, HRZN was trading at $6.57 on NASDAQ in the Unknown sector, with a market capitalization of approximately $295.1M. The 52-week trading range was $5.71 to $9.99. This filing was assessed with neutral market sentiment and an importance score of 9 out of 10.